Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1999;92(Suppl 37):2–12. doi: 10.1177/014107689909237s02

The practical application and interpretation of simple lung function tests in cystic fibrosis.

P L Brand 1, C K van der Ent 1
PMCID: PMC1297017  PMID: 10472246

Full text

PDF
2

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Braggion C., Pradal U., Mastella G., Coates A. L., Milic-Emili J. Effect of different inspiratory maneuvers on FEV1 in patients with cystic fibrosis. Chest. 1996 Sep;110(3):642–647. doi: 10.1378/chest.110.3.642. [DOI] [PubMed] [Google Scholar]
  2. Brand P. L., Kerstjens H. A., Postma D. S., Sterk P. J., Quanjer P. H., Sluiter H. J., Dijkman J. H., van Herwaarden C. L., Hilvering C., Jansen H. M. Long-term multicentre trial in chronic nonspecific lung disease: methodology and baseline assessment in adult patients. Dutch CNSLD Study Group. Eur Respir J. 1992 Jan;5(1):21–31. [PubMed] [Google Scholar]
  3. Brand P. L., Quanjer P. H., Postma D. S., Kerstjens H. A., Koëter G. H., Dekhuijzen P. N., Sluiter H. J. Interpretation of bronchodilator response in patients with obstructive airways disease. The Dutch Chronic Non-Specific Lung Disease (CNSLD) Study Group. Thorax. 1992 Jun;47(6):429–436. doi: 10.1136/thx.47.6.429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cheng K., Smyth R. L., Govan J. R., Doherty C., Winstanley C., Denning N., Heaf D. P., van Saene H., Hart C. A. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet. 1996 Sep 7;348(9028):639–642. doi: 10.1016/S0140-6736(96)05169-0. [DOI] [PubMed] [Google Scholar]
  5. Frederiksen B., Koch C., Høiby N. Antibiotic treatment of initial colonization with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration of pulmonary function in cystic fibrosis. Pediatr Pulmonol. 1997 May;23(5):330–335. doi: 10.1002/(sici)1099-0496(199705)23:5<330::aid-ppul4>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  6. Gurney J. W., Habbe T. G., Hicklin J. Distribution of disease in cystic fibrosis: correlation with pulmonary function. Chest. 1997 Aug;112(2):357–362. doi: 10.1378/chest.112.2.357. [DOI] [PubMed] [Google Scholar]
  7. Hamm H., Light R. W. The pleura: the outer space of pulmonary medicine. Eur Respir J. 1997 Jan;10(1):2–3. doi: 10.1183/09031936.97.10010002. [DOI] [PubMed] [Google Scholar]
  8. Høiby N. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa. Neth J Med. 1995 Jun;46(6):280–287. doi: 10.1016/0300-2977(95)00020-n. [DOI] [PubMed] [Google Scholar]
  9. Høiby N., Koch C. Cystic fibrosis. 1. Pseudomonas aeruginosa infection in cystic fibrosis and its management. Thorax. 1990 Nov;45(11):881–884. doi: 10.1136/thx.45.11.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Koller D. Y., Nilsson M., Enander I., Venge P., Eichler I. Serum eosinophil cationic protein, eosinophil protein X and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clin Exp Allergy. 1998 Feb;28(2):241–248. doi: 10.1046/j.1365-2222.1998.00216.x. [DOI] [PubMed] [Google Scholar]
  11. Ledson M. J., Gallagher M. J., Corkill J. E., Hart C. A., Walshaw M. J. Cross infection between cystic fibrosis patients colonised with Burkholderia cepacia. Thorax. 1998 May;53(5):432–436. doi: 10.1136/thx.53.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leeming J. P., Pryce-Roberts D. M., Kendrick A. H., Smith E. C. The efficacy of filters used in respiratory function apparatus. J Hosp Infect. 1995 Nov;31(3):205–210. doi: 10.1016/0195-6701(95)90067-5. [DOI] [PubMed] [Google Scholar]
  13. Mahadeva R., Webb K., Westerbeek R. C., Carroll N. R., Dodd M. E., Bilton D., Lomas D. A. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ. 1998 Jun 13;316(7147):1771–1775. doi: 10.1136/bmj.316.7147.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marchant J., Bush A. Prevention of cross infection during outpatient spirometry. Arch Dis Child. 1995 Feb;72(2):156–158. doi: 10.1136/adc.72.2.156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Milla C. E., Warwick W. J. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest. 1998 May;113(5):1230–1234. doi: 10.1378/chest.113.5.1230. [DOI] [PubMed] [Google Scholar]
  16. Miller M. R., Pincock A. C. Predicted values: how should we use them? Thorax. 1988 Apr;43(4):265–267. doi: 10.1136/thx.43.4.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ramsey B. W. Management of pulmonary disease in patients with cystic fibrosis. N Engl J Med. 1996 Jul 18;335(3):179–188. doi: 10.1056/NEJM199607183350307. [DOI] [PubMed] [Google Scholar]
  18. Redline S., Wright E. C., Kattan M., Kercsmar C., Weiss K. Short-term compliance with peak flow monitoring: results from a study of inner city children with asthma. Pediatr Pulmonol. 1996 Apr;21(4):203–210. doi: 10.1002/(SICI)1099-0496(199604)21:4<203::AID-PPUL1>3.0.CO;2-P. [DOI] [PubMed] [Google Scholar]
  19. Studnicka M., Frischer T., Neumann M. Determinants of reproducibility of lung function tests in children aged 7 to 10 years. Pediatr Pulmonol. 1998 Apr;25(4):238–243. doi: 10.1002/(sici)1099-0496(199804)25:4<238::aid-ppul4>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  20. Taylor M. R. Asthma: audit of peak flow rate guidelines for admission and discharge. Arch Dis Child. 1994 May;70(5):432–434. doi: 10.1136/adc.70.5.432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Vu-Thien H., Moissenet D., Valcin M., Dulot C., Tournier G., Garbarg-Chenon A. Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):876–879. doi: 10.1007/BF01691221. [DOI] [PubMed] [Google Scholar]
  22. Waalkens H. J., Merkus P. J., van Essen-Zandvliet E. E., Brand P. L., Gerritsen J., Duiverman E. J., Kerrebijn K. F., Knol K. K., Quanjer P. H. Assessment of bronchodilator response in children with asthma. Dutch CNSLD Study Group. Eur Respir J. 1993 May;6(5):645–651. [PubMed] [Google Scholar]
  23. Webb A. K., Govan J. R. Burkholderia cepacia: another twist and a further threat. Thorax. 1998 May;53(5):333–334. doi: 10.1136/thx.53.5.333. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wojnarowski C., Eichler I., Gartner C., Götz M., Renner S., Koller D. Y., Frischer T. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med. 1997 Jun;155(6):1902–1907. doi: 10.1164/ajrccm.155.6.9196093. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES